(EMAILWIRE.COM, August 03, 2018 ) ECMO (Extracorporeal membrane oxygenation) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream of a very sick baby. The system enables to provide heart-lung bypass route outside of the baby's body. This may provide help to support a child who need a heart or lung transplant. The main purpose of ECMO is to provide oxygen to the baby whose heart and lungs to heal or rest.

The market for the ECMO is driving due to the key factors such as rise in the number of heart and lung transplants, rise in the number of infants with the heart problem, rise in the number of patients with the breathing. In addition, to this the growing cases of the cardiovascular diseases and rising awareness among the people for heart and lung transplants. The populous regions have wide scope of opportunities for the players to produce more ECMO products as the rise in the growing geriatric population suffers from the cardiopulmonary diseases.

Get Sample PDF Illustration @ http://bit.ly/2JbmeJX

The "Global ECMO Market Analysis to 2025" is a specialized and in-depth study of the ECMO industry with a focus on the global market trend. The report aims to provide an overview of global ECMO market with detailed market segmentation by method, application and geography. The global ECMO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The ECMO market is segmented based on method and application. The method segment include venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The application segment is classified as cardiology, respiratory and others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global ECMO market based on type and application. It also provides market size and forecast till 2025 for overall ECMO market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to hold largest share of the ECMO market, followed by Europe. Asia Pacific are expected to grow at a fast rate during the analysis period, as the rise in the number of cardiovascular diseases, increase in birth defects of the heart, severe pneumonia and high blood pressure in the arteries of the lungs are leading to the growth of market across the world. In addition to this the reimbursement plans and the expenditures for the healthcare industries are growing the market. These factors widening the growth opportunities for the players and are likely to propel the growth of market in future.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Get your Customized Report @ http://bit.ly/2md3e4Z

The report also includes the profiles of key ECMO companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are TERUMO CORPORATION, Medtronic, MicroPort Scientific Corporation, ALung Technologies, Inc., NIPRO, EUROSETS, MAQUET Holding B.V. & Co. KG., LivaNova PLC, OriGen Biomedical, and XENIOS AG.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Contact Information:
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results